Publications by authors named "Alexandra U Scherrer"

55Publications

Antibodies against HPV16E6 oncoprotein in the Swiss HIV cohort study: Kinetics and anal cancer risk prediction.

Int J Cancer 2020 Aug 4;147(3):757-765. Epub 2019 Dec 4.

Division of Infectious Diseases and Hospital Epidemiology, University Hospital and University of Zurich, Zurich, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.32784DOI Listing
August 2020

The comparative effectiveness of NRTI-sparing dual regimens in emulated trials using observational data from the Swiss HIV Cohort Study.

Antivir Ther 2019 ;24(5):343-353

Basel Institute for Clinical Epidemiology and Biostatistics, University Hospital Basel, University of Basel, Basel, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3851/IMP3310DOI Listing
July 2020

HIV-1 Drug Resistance Among Ugandan Adults Attending an Urban Out-Patient Clinic.

J Acquir Immune Defic Syndr 2018 08;78(5):566-573

Research Department, Infectious Diseases Institute, College of Health Sciences, Makerere University, Kampala, Uganda.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAI.0000000000001717DOI Listing
August 2018

Long-term leukocyte reconstitution in NSG mice transplanted with human cord blood hematopoietic stem and progenitor cells.

BMC Immunol 2017 05 30;18(1):28. Epub 2017 May 30.

Division of Infectious Diseases and Hospital Epidemiology, University Hospital of Zurich, University of Zurich, Raemistrasse 100, 8091, Zurich, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12865-017-0209-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5450051PMC
May 2017

CD4/CD8 ratio and lung cancer risk.

Lancet HIV 2017 03;4(3):e103

Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2352-3018(17)30027-9DOI Listing
March 2017

Human papillomavirus antibody response following HAART initiation among MSM.

AIDS 2017 02;31(4):561-569

aInternational Agency for Research on Cancer, Lyon, FrancebInstitute of Social and Preventive Medicine, University of Bern, BerncDivision of Infectious Diseases, University Hospital Lausanne, LausannedDivision of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, BaseleDepartment of Infectious Diseases, Bern University Hospital, University of Bern, BernfHIV/AIDS Unit, Infectious Disease Service, Geneva University Hospital, GenevagDivision of Infectious Diseases, Cantonal Hospital St. Gallen, St. GallenhDivision of Infectious Diseases, Regional Hospital Lugano, LuganoiDivision of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of ZurichjInstitute of Medical Virology, University of Zurich, Zurich, SwitzerlandkInfection and Cancer Program, German Cancer Research Center, Heidelberg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAD.0000000000001354DOI Listing
February 2017

Early virological failure and HIV drug resistance in Ugandan adults co-infected with tuberculosis.

AIDS Res Ther 2017 Jan 5;14(1). Epub 2017 Jan 5.

Infectious Diseases Institute, College of Health Sciences, Makerere University, Kampala, Uganda.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12981-016-0128-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5237283PMC
January 2017

Factors associated with syphilis incidence in the HIV-infected in the era of highly active antiretrovirals.

Medicine (Baltimore) 2017 Jan;96(2):e5849

aDivision of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich bInstitute of Medical Virology, University of Zurich, Zurich cBasel Institute for Clinical Epidemiology and Biostatistics, University Hospital Basel, Basel dInfectious Diseases Department, Genève University Hospital, Genève eInfectious Diseases Department, Lausanne University Hospital, Lausanne fDivision of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, Basel gDivision of Infectious Diseases and Hospital Epidemiology, Kantonal Hospital St. Gallen, St. Gallen hDivision of Infectious Diseases, Regional Hospital Lugano, Lugano iDepartment of Infectious Diseases, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MD.0000000000005849DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5266180PMC
January 2017

Incidence of hepatitis C in HIV positive and negative men who have sex with men 2000-2016: a systematic review and meta-analysis.

Infection 2017 Jun 22;45(3):309-321. Epub 2016 Dec 22.

Division of Infectious Diseases and Hospital Epidemiology, University Hospital of Zurich, University of Zurich, Zurich, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s15010-016-0975-yDOI Listing
June 2017

HIV-1 Subtype C, Tenofovir, and the Relationship With Treatment Failure and Drug Resistance.

J Infect Dis 2016 11 24;214(9):1289-1291. Epub 2016 May 24.

Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich and Institute of Medical Virology, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/infdis/jiw214DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5079362PMC
November 2016

Prosthetic Vascular Graft Infections: Bacterial Cultures from Negative-Pressure-Wound-Therapy Foams Do Not Improve Diagnostics.

J Clin Microbiol 2016 08 1;54(8):2190-3. Epub 2016 Jun 1.

Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1128/JCM.01102-16DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4963492PMC
August 2016

Dually Active HIV/HBV Antiretrovirals as Protection Against Incident Hepatitis B Infections: Potential for Prophylaxis.

J Infect Dis 2016 Aug 18;214(4):599-606. Epub 2016 May 18.

Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich Institute of Medical Virology, University of Zurich.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/infdis/jiw195DOI Listing
August 2016

Successful Prevention of Transmission of Integrase Resistance in the Swiss HIV Cohort Study.

J Infect Dis 2016 08 29;214(3):399-402. Epub 2016 Apr 29.

Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Institute of Medical Virology, University of Zurich.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/infdis/jiw165DOI Listing
August 2016

Assessing efficacy of different nucleos(t)ide backbones in NNRTI-containing regimens in the Swiss HIV Cohort Study.

J Antimicrob Chemother 2015 Dec 11;70(12):3323-31. Epub 2015 Sep 11.

Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland Institute of Medical Virology, University of Zurich, Zurich, Switzerland

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jac/dkv257DOI Listing
December 2015

Persistence of transmitted HIV-1 drug resistance mutations associated with fitness costs and viral genetic backgrounds.

PLoS Pathog 2015 Mar 23;11(3):e1004722. Epub 2015 Mar 23.

Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland; Institute of Medical Virology, University of Zurich, Zurich, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1371/journal.ppat.1004722DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4370492PMC
March 2015

Prevalence and predictors for homo- and heterosubtypic antibodies against influenza a virus.

Clin Infect Dis 2014 Nov 18;59(10):1386-93. Epub 2014 Aug 18.

Institute of Medical Virology, University of Zurich.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/cid/ciu660DOI Listing
November 2014

Limited clinical benefit of minority K103N and Y181C-variant detection in addition to routine genotypic resistance testing in antiretroviral therapy-naive patients.

AIDS 2014 Sep;28(15):2231-9

aDivision of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich bInstitute of Medical Virology, Swiss National Center for Retroviruses, University of Zurich, Zurich cLaboratory of Virology and AIDS Center, University Hospital Geneva, Geneva dDepartment of Biomedicine, Haus Petersplatz, University of Basel, Basel eDivision of Immunology, University Hospital Lausanne, Lausanne fDepartment of Infectious Diseases, Bern University Hospital and University of Bern, Bern gDivision of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, University of Basel, Basel hDivision of Infectious Diseases, Cantonal Hospital St. Gallen, St. Gallen iInfectious Diseases Service, University Hospital Lausanne, Lausanne jDivision of Infectious Diseases, Geneva University Hospitals, Geneva kDivision of Infectious Diseases, Regional Hospital Lugano, Lugano, Switzerland. *Karin J. Metzner, Alexandra U. Scherrer and Viktor Von Wyl contributed equally to this work.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAD.0000000000000397DOI Listing
September 2014